Test Anxiety on Bowel Health and Constipation in Students

June 12, 2026 updated by: Demet Öztürk, Lokman Hekim University

The Effect of Test Anxiety on Bowel Health and Constipation in University Students

This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.

Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.

The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.

This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.

After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.

The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.

Study Type

Observational

Enrollment (Estimated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Ankara
      • Ankara, Ankara, Turkey (Türkiye), 06510
        • Recruiting
        • Lokman Hekim University, Ankara, Ankara
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study population will include undergraduate Physiotherapy and Rehabilitation students at Lokman Hekim University who are in their final examination period during the data collection process. Eligible participants will be 18 years of age or older, able to read and complete the self-report questionnaires independently, and willing to provide written informed consent.

Description

Inclusion Criteria:

  • Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
  • Being in the final examination period during the data collection process
  • Having sufficient reading and comprehension skills to complete the questionnaires independently
  • Voluntarily agreeing to participate in the study after reading and signing the informed consent form

Exclusion Criteria:

  • Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
  • Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
  • Regular use of laxatives or medications that directly affect bowel movements, such as opioids
  • Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
  • Having had an acute gastrointestinal infection within the last month

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period. Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
Participants completed assessment forms and diaries. No intervention was administered.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constipation Status Assessed by the Rome IV Criteria
Time Frame: At a single assessment during the final examination period
Constipation status will be assessed using the Rome IV criteria. Participants will be classified as having constipation or not having constipation according to the presence of constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers.
At a single assessment during the final examination period

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Constipation Severity Assessed by the Constipation Severity Instrument
Time Frame: At a single assessment during the final examination period
Constipation severity will be assessed using the Constipation Severity Instrument. The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain. The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
At a single assessment during the final examination period
Stool Form Assessed by the Bristol Stool Scale
Time Frame: At a single assessment during the final examination period
Stool form will be assessed using the Bristol Stool Scale. Participants will be asked to select the stool type that best represents their most common stool form during the last week. The scale classifies stool form into seven types, ranging from hard separate lumps to watery stool.
At a single assessment during the final examination period
Test Anxiety Level Assessed by the Test Anxiety Inventory
Time Frame: At a single assessment during the final examination period
Test anxiety level will be assessed using the Test Anxiety Inventory. The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations. Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
At a single assessment during the final examination period
Bowel Habits and Bowel-Related Symptoms
Time Frame: At a single assessment during the final examination period
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form. The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
At a single assessment during the final examination period

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2026

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

February 25, 2027

Study Registration Dates

First Submitted

June 12, 2026

First Submitted That Met QC Criteria

June 12, 2026

First Posted (Actual)

June 17, 2026

Study Record Updates

Last Update Posted (Actual)

June 17, 2026

Last Update Submitted That Met QC Criteria

June 12, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Constipation

Clinical Trials on Observational assessment

Subscribe